UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Factors affecting the maintenance dose of warfarin

Journal of clinical pathology, 1992-08, Vol.45 (8), p.704-706

1992

Volltextzugriff (PDF)

Predicting HIV disease progression in children using measures of neuropsychological and neurological functioning. Pediatric AIDS clinical trials 152 study team

Pediatrics (Evanston), 2000-12, Vol.106 (6), p.E76

2000

Volltextzugriff (PDF)

Neurologic, neurocognitive, and brain growth outcomes in human immunodeficiency virus-infected children receiving different nucleoside antiretroviral regimens. Pediatric AIDS Clinical Trials Group 152 Study Team

Pediatrics (Evanston), 1999-09, Vol.104 (3), p.e32

1999

Volltextzugriff (PDF)

Short-Term Safety and Antiretroviral Activity of T-1249, a Second-Generation Fusion Inhibitor of HIV

The Journal of infectious diseases, 2004-03, Vol.189 (6), p.1075-1083

2004

Volltextzugriff (PDF)

T-1249 Retains Potent Antiretroviral Activity in Patients Who Had Experienced Virological Failure while on an Enfuvirtide-Containing Treatment Regimen

The Journal of infectious diseases, 2005-04, Vol.191 (7), p.1155-1163

2005

Volltextzugriff (PDF)

Variations in the use of coronary arteriography in the UK: the RITA trial coronary arteriogram register

QJM : An International Journal of Medicine, 1995-03, Vol.88 (3), p.167-173

1995

Volltextzugriff (PDF)

Prothrombin activation fragment 1 + 2 and thrombin antithrombin III complexes in patients with angina pectoris: relation to the presence and severity of coronary atherosclerosis

Thrombosis and haemostasis, 1993-10, Vol.70 (4), p.550-553

1993

Volltextzugriff (PDF)

Genetic Influence of CCR5, CCR2 and SDF1 Variants on Human Immunodeficiency Virus 1 (HIV-1)–Related Disease Progression and Neurological Impairment, in Children with Symptomatic HIV-1 Infection

The Journal of infectious diseases, 2003-11, Vol.188 (10), p.1461-1472

2003

Volltextzugriff (PDF)

Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children

JAMA : the journal of the American Medical Association, 1998-03, Vol.279 (10), p.756

1998

Volltextzugriff (PDF)

Factors affecting the precision of warfarin treatment

Journal of clinical pathology, 1992-11, Vol.45 (11), p.1003-1006

1992

Volltextzugriff (PDF)

Zidovudine, Didanosine, or Both as the Initial Treatment for Symptomatic HIV-Infected Children

The New England journal of medicine, 1997-06, Vol.336 (24), p.1704-1712

1997

Volltextzugriff (PDF)

Comparative long-term results of coronary angioplasty in single and multivessel disease

European heart journal, 1992-06, Vol.13 (6), p.781-786

1992

Volltextzugriff (PDF)

The CCR5Δ32 Allele Slows Disease Progression of Human Immunodeficiency Virus—1—Infected Children Receiving Antiretroviral Treatment

The Journal of infectious diseases, 2000-08, Vol.182 (2), p.413-419

2000

Volltextzugriff (PDF)

Mutations linked to drug resistance, human immunodeficiency virus type 1 biologic phenotype and their association with disease progression in children receiving nucleoside reverse transcriptase inhibitors

The Pediatric infectious disease journal, 2004-01, Vol.23 (1), p.15-22

2004

Volltextzugriff (PDF)

Neurologic, Neurocognitive, and Brain Growth Outcomes in Human Immunodeficiency Virus-Infected Children Receiving Different Nucleoside Antiretroviral Regimens

Pediatrics (Evanston), 1999-09, Vol.104 (3), p.e32-e32

1999

Volltextzugriff (PDF)

Predicting HIV Disease Progression in Children Using Measures of Neuropsychological and Neurological Functioning

Pediatrics (Evanston), 2000-12, Vol.106 (6), p.e76-e76

2000

Volltextzugriff (PDF)

The CCR5 Delta 32 allele slows disease progression of human immunodeficiency virus-1-infected children receiving antiretroviral treatment

The Journal of infectious diseases, 2000-08, Vol.182 (2), p.413-419

2000

Volltextzugriff (PDF)

Prediction of short-term survival with an application in primary biliary cirrhosis

Statistics in medicine, 1992, Vol.11 (13), p.1731-1745

1992

Volltextzugriff (PDF)

Prevalence of chemokine and chemokine receptor polymorphisms in seroprevalent children with symptomatic HIV-1 infection in the United States

Journal of acquired immune deficiency syndromes (1999), 2004-03, Vol.35 (3), p.309-313

2004

Volltextzugriff (PDF)

Virologic and Immunologic Response to Nucleoside Reverse-Transcriptase Inhibitor Therapy among Human Immunodeficiency Virus—Infected Infants and Children

The Journal of infectious diseases, 1999-03, Vol.179 (3), p.576-583

1999

Volltextzugriff (PDF)

Clinical and Laboratory Characteristics of a Large Cohort of Symptomatic, Human Immunodeficiency Virus-infected Infants and Children

The Pediatric infectious disease journal, 1996-11, Vol.15 (11), p.1025-1036

1996

Volltextzugriff (PDF)

The CCR5Delta32 allele slows disease progression of human immunodeficiency virus-1-infected children receiving antiretroviral treatment

The Journal of infectious diseases, 2000-08, Vol.182 (2), p.413-419

2000

Volltextzugriff (PDF)

Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team

The New England journal of medicine, 1997-06, Vol.336 (24), p.1704

1997

Volltextzugriff (PDF)

Clinical and laboratory characteristics of a large cohort of symptomatic, human immunodeficiency virus-infected infants and children. AIDS Clinical Trials Group Protocol 152 Study Team

The Pediatric infectious disease journal, 1996-11, Vol.15 (11), p.1025

1996

Volltextzugriff (PDF)

Poor prognostication for survival of individual PBC patients with Cox models

Journal of hepatology, 1990, Vol.11, p.S7-S7

1990

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Factors affecting the maintenance dose of warfarin

Predicting HIV disease progression in children using measures of neuropsychological and neurological functioning. Pediatric AIDS clinical trials 152 study team

Neurologic, neurocognitive, and brain growth outcomes in human immunodeficiency virus-infected children receiving different nucleoside antiretroviral regimens. Pediatric AIDS Clinical Trials Group 152 Study Team

Short-Term Safety and Antiretroviral Activity of T-1249, a Second-Generation Fusion Inhibitor of HIV

T-1249 Retains Potent Antiretroviral Activity in Patients Who Had Experienced Virological Failure while on an Enfuvirtide-Containing Treatment Regimen

Variations in the use of coronary arteriography in the UK: the RITA trial coronary arteriogram register

Prothrombin activation fragment 1 + 2 and thrombin antithrombin III complexes in patients with angina pectoris: relation to the presence and severity of coronary atherosclerosis

Genetic Influence of CCR5, CCR2 and SDF1 Variants on Human Immunodeficiency Virus 1 (HIV-1)–Related Disease Progression and Neurological Impairment, in Children with Symptomatic HIV-1 Infection

Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children

Factors affecting the precision of warfarin treatment

Zidovudine, Didanosine, or Both as the Initial Treatment for Symptomatic HIV-Infected Children

Comparative long-term results of coronary angioplasty in single and multivessel disease

The CCR5Δ32 Allele Slows Disease Progression of Human Immunodeficiency Virus—1—Infected Children Receiving Antiretroviral Treatment

Mutations linked to drug resistance, human immunodeficiency virus type 1 biologic phenotype and their association with disease progression in children receiving nucleoside reverse transcriptase inhibitors

Neurologic, Neurocognitive, and Brain Growth Outcomes in Human Immunodeficiency Virus-Infected Children Receiving Different Nucleoside Antiretroviral Regimens

Predicting HIV Disease Progression in Children Using Measures of Neuropsychological and Neurological Functioning

The CCR5 Delta 32 allele slows disease progression of human immunodeficiency virus-1-infected children receiving antiretroviral treatment

Prediction of short-term survival with an application in primary biliary cirrhosis

Prevalence of chemokine and chemokine receptor polymorphisms in seroprevalent children with symptomatic HIV-1 infection in the United States

Virologic and Immunologic Response to Nucleoside Reverse-Transcriptase Inhibitor Therapy among Human Immunodeficiency Virus—Infected Infants and Children

Clinical and Laboratory Characteristics of a Large Cohort of Symptomatic, Human Immunodeficiency Virus-infected Infants and Children

The CCR5Delta32 allele slows disease progression of human immunodeficiency virus-1-infected children receiving antiretroviral treatment

Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team

Clinical and laboratory characteristics of a large cohort of symptomatic, human immunodeficiency virus-infected infants and children. AIDS Clinical Trials Group Protocol 152 Study Team

Poor prognostication for survival of individual PBC patients with Cox models

Suchergebnisse filtern